An issue with any platform, provider, or pharmacy affects the process
More significant weight loss and body composition improvements typically occur over the course of several months with consistent therapy and lifestyle adjustments
For weight loss, healthcare professionals may prescribe GLP-1 receptor agonists if you have a starting body mass index (BMI) of 30 or higher or if you have a BMI of 27 or higher and at least 1 weight-related health condition, including: Type 2 diabetes Cardiovascular disease High blood pressure High cholesterol Liver disease Polycystic ovary syndrome Obstructive sleep apnea What are the common side effects of GLP-1 receptor agonists
Seek urgent medical advice (contact your GP or NHS 111) if you experience: Severe or persistent abdominal pain, especially if accompanied by vomiting Persistent vomiting or inability to keep fluids down Signs of dehydration (extreme thirst, dark urine, dizziness) Sudden severe upper abdominal pain radiating to the back (possible pancreatitis) Severe right upper abdominal pain (possible gallstones) Severe bloating with vomiting and no passage of stool or gas (possible obstruction) Persistent or severe gastrointestinal symptoms may indicate the need for dose adjustment or, rarely, discontinuation of therapy
Intramuscular injection is not recommended and may alter absorption rates or increase adverse effects
